Phospholipase A2 activity in normal and Staphylococcus aureus-infected rabbit eyes

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 1, 2003, Pages 197-202

  Girgis, Dalia O ^a   Dajcs, Joseph J ^a   O'Callaghan, Richard J ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LSU EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; MYELOPEROXIDASE; PHOSPHOLIPASE A2; PEROXIDASE; PHOSPHOLIPASE A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARACHIDONIC ACID METABOLISM; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME ACTIVITY; EYE INFECTION; HOST RESISTANCE; KERATITIS; LACRIMAL FLUID; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RABBIT; SLEEP; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; AGING; ANIMAL; BACTERIAL EYE INFECTION; CORNEA; ENZYMOLOGY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; TIME;

AGING; ANIMALS; AQUEOUS HUMOR; CORNEA; EYE INFECTIONS, BACTERIAL; KERATITIS; PEROXIDASE; PHOSPHOLIPASES A; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEARS; TIME FACTORS;

EID: 0037207477     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0548     Document Type: Article

References (52)

1. Yamamoto GK, Allansmith MR. Complement in tears from normal humans. Am J Ophthalmol. 1979;88:758-763.
2. Bron AJ, Seal DV. The defenses of the ocular surface. Trans Ophthalmol Soc UK. 1986;105:18-25.
3. Cullor JS, Mannis MJ, Murphy CJ, Smith WL, Selsted ME, Reid TW. In vitro antimicrobial activity of defensins against ocular pathogens. Arch Ophthalmol. 1990;108:861-864.
4. Berta A. Enzymology of the Tears. Boca Raton, FL: CRC Press; 1992;19-28.
5. Weissman BA, Giese MJ, Mondino BJ. An introduction to ocular immunology. Optom Clin. 1994;3:1-22.
6. Kijlstra A, Kuizenga A. Analysis and function of the human tear proteins. Adv Exp Med Biol. 1994;350:299-308.
7. Haynes RJ, Tighe PJ, Dua HS. Antimicrobial defensin peptides of the human ocular surface. Br J Ophthalmol. 1999;83:737-741.
8. 2 against Staphylococcus aureus. J Immunol. 1999;162:7402-7408.
9. 2 against grossly clumped Staphylococcus aureus. Infect Immun. 1999;67:2299-2305.
10. Foreman-Wykert AK, Weinrauch Y, Elsbach P, Weiss J. Cell-wall determinants of the bactericidal action of group IIA phospholipase A(2) against Gram-positive bacteria. J Clin Invest. 1999;103:715-721.
11. Weinrauch Y, Elsbach P, Masen LM, Foreman A, Weiss J. The potent anti-Staphylococcus aureus activity of sterile rabbit inflammatory fluid is due to 14-kD phospholipase A2. J Clin Invest. 1996;97:250-257.
12. 2. J Immunol. 2001;166:4029-4034.
13. 2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect Immun. 1998;66:2791-2797.
14. 2 in rabbit tears: a host defense against Staphylococcus aureus. Invest Ophthalmol Vis Sci. 2001;42:2347-2354.
15. Hume EBH, Dajcs JJ, Moreau JM, Sloop GD, Willcox MDP, O'Callaghan RJ. Staphylococcus corneal virulence in a new topical model of infection. Invest Ophthalmol Vis Sci. 2001;42:2904-2908.
16. 2 on cell membranes. J Biol Chem. 1998;273:32142-32153.
17. 2 expression and inflammation: the relationship with associated disease states. J Lipid Mediat. 1993;8:1-30.
18. 2 in human tissues. Inflammation. 1993;17:453-464.
19. 2. Biochem Soc Trans. 1990;18:781-785.
20. 2 - basic and clinical aspects of inflammatory diseases. Prog Surg. 1997;24:31-37.
21. Nevalainen TJ, Aho HJ, Peuravuori H. Secretion of group 2 phospholipase A2 by lacrimal glands. Invest Ophthalmol Vis Sci. 1994;35:417-421.
22. Liesgang TJ. Bacterial and fungal keratitis. In: Kaufman HE, Baron BA, McDonald MB, eds. The Cornea. Boston, MA: Butterworth-Heineman 1998;159-219.
23. Asbell P, Stenson S. Ulcerative keratitis: a 30 years' laboratory experience. Arch Ophthalmol. 1982;100:77-80.
24. Gudmundsson OG, Ormerod L, Kenyon KR, et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea. 1989;8:115-121.
25. Cruz OA, Sabir SM, Capo H, Alfonso E. Microbial keratitis in childhood. Ophthalmology. 1993;100:192-196.
26. Wang AG, Wu CC, Liu JH. Bacterial corneal ulcers: a multivariate study. Ophthalmologica. 1998;212:216-232.
27. Kerr N, Stem GA. Bacterial keratitis associated with vernal keratoconjunctivitis. Cornea. 1992;11:355-359.
28. Palmer ML, Hyndiuk MD. Contact lens-related infectious keratitis. Int Ophthalmol Clin. 1993;33:23-49.
29. Ghabrial R, Climent A, Cevallos VE, Ostler BH. Laboratory results of corneal scrapings in microbial keratitis. Ann Ophthalmol. 1995;27:40-45.
30. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology. 2000;107:1497-1502.
31. Brockman EB, Tarantino PA, Hobden JA, et al. Keratotomy model of Pseudomonas keratitis: gentamicin chemotherapy. Refract Corneal Surg. 1992;8:39-43.
32. Matoba AY, Hamill RJ, Osata MS. The effects of fibronectin on the adherence of bacteria to corneal epithelium. Cornea. 1991;10:387-389.
33. O'Callaghan RJ, Engel LS, Hill JM. The rabbit intrastromal infection model of bacterial keratitis. In: Zak O, Sande M, eds. Handbook of Animal Models of Infection. London: Academic Press; 1999;367-374.
34. Callegan MC, Engel LS, Hill JM, O'Callaghan RJ. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun. 1994;62:2478-2482.
35. O'Callaghan RJ, Callegan MC, Moreau JM, et al. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997;65:1571-1578.
36. Sloop GD, Moreau JM, Conerly LL, Dajcs JJ, O'Callaghan RJ. Acute inflammation of the eyelid and cornea in Staphylococcus keratitis in the rabbit. Invest Ophthalmol Vis Sci. 1999;40:385-391.
37. Hobden JA, Engel LS, Callegan MC, Hill JM, Gebhardt BM, O'Callaghan RJ. Pseudomonas aeruginosa keratitis in leukopenic rabbits. Curr Eye Res. 1993;12:461-467.
38. Hobden JA, Hill JM, Engel LS, O'Callaghan RJ. Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treated with ciprofloxacin, prednisolone and flurbiprofen. Antimicrob Agents Chemother. 1993;37:1856-1859.
39. 2 content of tears in normal subjects. Invest Ophthalmol Vis Sci. 2001;42:318-320.
40. Stapleton F, Willcox MD, Morris CA, Sweeney DF. Tear changes in contact lens wearers following overnight eye closure. Curr Eye Res. 1998;17:183-188.
41. Sack RA, Tan KO, Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest Ophthalmol Vis Sci. 1992;33:626-640.
42. Tan KO, Sack RA, Holden BA, Swarbrick HA. Temporal sequences of changes in tear film composition during sleep. Curr Eye Res. 1993;12:1001-1007.
43. Willcox MD, Morris CA, Sack RA, Thakur A, Tipireddy S, Boey W. Complement and complement regulatory proteins in human tears. Invest Ophthalmol Vis Sci. 1997;38:1-8.
44. 2 in human polymorphonuclear leukocytes. Biochim Biophys Acta. 1986;879:149-156.
45. 2 in granules and secrete active enzyme in response to soluble stimuli. Biochim Biophys Res Commun. 1995;208:650-656.
46. Moreau JM, Sloop GD, Engel LS, Hill JM, O'Callaghan RJ. Histopathological studies of Staphylococcus alpha-toxin effects on rabbit corneas. Curr Eye Res. 1997;16:1221-1228.
47. Ben-Zvi A, Rodrigues MM, Gery I, Schiffman E. Induction of ocular inflammation by synthetic mediators. Arch Ophthalmol. 1981;99:1436-1444.
48. Wakefield D, Lloyd A. The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine. 1992;4:1-5.
49. 2 activity in the tears of chronic blepharitis patients. Invest Ophthalmol Vis Sci. 1999;40:2744-2748.
50. Aho VV, Nevalainen TJ, Saari KM. Group IIA phospholipase A2 content of tears in patients with keratoconjunctivitis sicca. Graefes Arch Clin Exp Ophthalmol. 2002;240:521-523.
51. Chusid MJ, Davis SD. Pathogenesis of corneal and conjunctival infections. In: Tabbar KF, Hyndiuk RA, eds. Infections of the Eye. Boston, MA: Little, Brown, & Co; 1986:45-62.
52. Kenyon KR, Chaves HV. Morphology and pathologic response of corneal and conjunctival disease. In: Smolin G, Thoft KA, eds. The Cornea: Scientific Foundations and Clinical Practice. Boston: Little, Brown & Co; 1994:69-111.